Sichuan Tiancheng Pharmaceutical Co., Ltd., commonly referred to as Tiancheng Pharma, is a prominent player in the pharmaceutical industry, headquartered in Chengdu, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern pharmaceuticals. With a strong operational presence across various regions in China, Tiancheng Pharma focuses on innovative drug formulations and active pharmaceutical ingredients (APIs). Their core offerings include a diverse range of medications that cater to both chronic and acute health conditions, distinguished by their commitment to quality and efficacy. Recognised for its robust research and development capabilities, Sichuan Tiancheng Pharmaceutical has achieved notable milestones, positioning itself as a trusted name in the market. The company continues to expand its influence, contributing to advancements in healthcare solutions both domestically and internationally.
How does Sichuan Tiancheng Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sichuan Tiancheng Pharmaceutical Co., Ltd.'s score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sichuan Tiancheng Pharmaceutical Co., Ltd., headquartered in China (CN), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary and inherits data from its parent organization, CECEP Solar Energy Co., Ltd., at a cascade level of 1. However, no specific emissions metrics or reduction targets have been disclosed. In terms of climate commitments, Sichuan Tiancheng Pharmaceutical has not established any documented reduction targets or climate pledges. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As a part of the pharmaceutical industry, Sichuan Tiancheng Pharmaceutical is positioned within a sector that is increasingly focusing on sustainability and carbon reduction. The absence of specific emissions data and targets highlights an opportunity for the company to enhance its environmental accountability and align with industry standards for climate action.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sichuan Tiancheng Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.